Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and strokeGIDAL, B. E; CRISMON, M. L; WAGNER, M. L et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 12, pp 1446-1451, issn 1060-0280Article

Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapyBOWES, M. P; ROTHLEIN, R; FAGAN, S. C et al.Neurology. 1995, Vol 45, Num 4, pp 815-819, issn 0028-3878Article

Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbitsBOWES, M. P; ZIVIN, J. A; THOMAS, G. R et al.Experimental neurology (Print). 1996, Vol 141, Num 1, pp 40-46, issn 0014-4886Article

Current developments in neurology, part I : Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosisGIDAL, B. E; WAGNER, M. L; PRIVITERA, M. D et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 11, pp 1272-1276, issn 1060-0280Article

Nimodipine disposition and heamodynamic effects in patients with cirrhosis and age-matched controlsGENGO, F. M; FAGAN, S. C; KROL, G et al.British journal of clinical pharmacology. 1987, Vol 23, Num 1, pp 47-53, issn 0306-5251Article

Thrombolysis in acute ischemic strokeDUMO, P; FAGAN, S. C; CARHUAPOMA, J et al.American journal of health-system pharmacy. 1997, Vol 54, Num 19, pp 2213-2217, issn 1079-2082Article

Hemorrhagic transformation in focal cerebral ischemia : Influence of time to artery reopening and tissue plasminogen activatorFAGAN, S. C; GARCIA, J. H.Pharmacotherapy. 1999, Vol 19, Num 2, pp 139-142, issn 0277-0008Article

Ticlopidine : a new antiplatelet agent for cerebrovascular diseaseROBERT, S; MILLER, A. J; FAGAN, S. C et al.Pharmacotherapy. 1991, Vol 11, Num 4, pp 317-325, issn 0277-0008Article

Prostanoid concentrations in human CSF following acute ischaemic brain infarctionFAGAN, S. C; CASTELLANI, D; GENGO, F. M et al.Clinical and experimental pharmacology and physiology. 1986, Vol 13, Num 8, pp 629-632, issn 0305-1870Article

Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model : Effect of labetalolFAGAN, S. C; BOWES, M. P; LYDEN, P. D et al.Experimental neurology (Print). 1998, Vol 150, Num 1, pp 153-158, issn 0014-4886Article

Cost-effectiveness of tissue plasminogen activator for acute ischemic strokeFAGAN, S. C; MORGENSTERN, L. B; BROTT, T. G et al.Neurology. 1998, Vol 50, Num 4, pp 883-890, issn 0028-3878Article

Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. CommentaryKNIGHT, R. A; BARKER, P. B; FAGAN, S. C et al.Stroke (1970). 1998, Vol 29, Num 1, pp 144-151, issn 0039-2499Conference Paper

Risk of cerebral hypoperfusion with antihypertensive therapyFAGAN, S. C; PAYNE, L. W; HOUTEKIER, S. C et al.DICP (Cincinnati, Ohio). 1989, Vol 23, Num 12, pp 957-961, issn 1042-9611Article

Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment. CommentaryRAVINA, B. M; FAGAN, S. C; HART, R. G et al.Neurology. 2003, Vol 60, Num 8, issn 0028-3878, 1225,1234-1240 [8 p.]Article

The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegiaTIEN MH NG; KOHLI, A; FAGAN, S. C et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 1, pp 39-43, issn 1060-0280Article

Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive diseasePATEL, R. V; RAMADAN, N. M; LEVINE, S. R et al.Journal of cardiovascular pharmacology. 1996, Vol 28, Num 1, pp 48-52, issn 0160-2446Article

Labetalol : response and safety in critically ill hemorrhagic stroke patientsPATEL, R. V; KERTLAND, H. R; JAHNS, B. F et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 2, pp 180-181, issn 1060-0280Article

Transcranial Doppler to evaluate the effects of antihypertensive medication on cerebral blood flow velocityFAGAN, S. C; BINDLISH, V; ROBERT, S et al.Journal of clinical pharmacology. 1992, Vol 32, Num 1, pp 66-69, issn 0091-2700Article

Acute toxicity of a nuclear magnetic renonance cerebral blood flow indicator in catsBRANCH, C. A; EWING, J. R; FAGAN, S. C et al.Stroke (1970). 1990, Vol 21, Num 8, pp 1172-1177, issn 0039-2499, 6 p.Article

Neuroprotective agents for clinical trials in ALS : A systematic assessmentTRAYNOR, B. J; BRUIJN, L; CONWIT, R et al.Neurology. 2006, Vol 67, Num 1, pp 20-27, issn 0028-3878, 8 p.Article

Hypertension and its treatment in the NINDS rt-PA Stroke trialBROTT, T; MEI LU; MARLER, J. R et al.Stroke (1970). 1998, Vol 29, Num 8, pp 1504-1509, issn 0039-2499Article

Accelerated intracranial occlusive disease, oral contraceptives, and cigarette useLEVINE, S. R; FAGAN, S. C; PESSIN, M. S et al.Neurology. 1991, Vol 41, Num 12, pp 1893-1901, issn 0028-3878Article

Effect of nimodipine on blood pressure in acute ischemic stroke in humansFAGAN, S. C; GENGO, F. M; BATES, V et al.Stroke (1970). 1988, Vol 19, Num 3, pp 401-402, issn 0039-2499Article

The effect of β-blockers on mental performance on older hypertensive patientsGENGO, F. M; FAGAN, S. C; DE PADOVA, A et al.Archives of internal medicine (1960). 1988, Vol 148, Num 4, pp 779-784, issn 0003-9926Conference Paper

Serum concentrations of propranolol and migraine prophylaxisGENGO, F. M; FAGAN, S. C; KINKEL, W. R et al.Archives of neurology (Chicago). 1984, Vol 41, Num 12, pp 1306-1307, issn 0003-9942Article